Lung Cancer in the Netherlands.

Autor: Hendriks LEL; Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands. Electronic address: lizza.hendriks@mumc.nl., Dingemans AC; Department of Pulmonary Diseases, GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., De Ruysscher DKM; Department of Radiation Oncology (Maastro), GROW-School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands., Aarts MJ; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands., Barberio L; Patient Foundation Lung Cancer Netherlands, Utrecht, The Netherlands., Cornelissen R; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hartemink KJ; Department of Thoracic Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., van den Heuvel M; Department of Pulmonary Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Schuuring E; Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Smit HJM; Department of Pulmonary Diseases, Rijnstate Hospital, Arnhem, The Netherlands., van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Jazyk: angličtina
Zdroj: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2021 Mar; Vol. 16 (3), pp. 355-365.
DOI: 10.1016/j.jtho.2020.10.012
Databáze: MEDLINE